Guido Moll

About Guido Moll

Guido Moll, With an exceptional h-index of 29 and a recent h-index of 27 (since 2020), a distinguished researcher at Charité - Universitätsmedizin Berlin, specializes in the field of Immunology, Translational Medicine, Regenerative Medicine, Cell Therapy, Bioengineering.

His recent articles reflect a diverse array of research interests and contributions to the field:

Emerging talents in alloimmunity and transplantation: 2022

Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection

Integrative Systems Immunology Analysis Reveals Elevated Anti-AGTR1 Levels with Accumulating COVID-19 Symptoms

Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA …

Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium

Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID‐19 severity

Vasoregulatory Autoantibodies and Clinical Outcome After Ischemic Stroke—PROSCIS‐B

Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α …

Guido Moll Information

University

Position

___

Citations(all)

4315

Citations(since 2020)

2973

Cited By

2541

hIndex(all)

29

hIndex(since 2020)

27

i10Index(all)

37

i10Index(since 2020)

36

Email

University Profile Page

Google Scholar

Guido Moll Skills & Research Interests

Immunology

Translational Medicine

Regenerative Medicine

Cell Therapy

Bioengineering

Top articles of Guido Moll

Emerging talents in alloimmunity and transplantation: 2022

2024/3/15

Guido Moll
Guido Moll

H-Index: 21

Olaf Penack
Olaf Penack

H-Index: 28

Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection

Frontiers in Immunology

2024/2/20

Integrative Systems Immunology Analysis Reveals Elevated Anti-AGTR1 Levels with Accumulating COVID-19 Symptoms

2024

Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA …

Journal of Clinical Medicine

2023/3/16

Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium

2023/3/10

Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID‐19 severity

Journal of Medical Virology

2023/2

Vasoregulatory Autoantibodies and Clinical Outcome After Ischemic Stroke—PROSCIS‐B

Journal of the American Heart Association

2023/12/5

Guido Moll
Guido Moll

H-Index: 21

Matthias Endres
Matthias Endres

H-Index: 65

Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α …

Frontiers in Immunology

2023/10/30

Neuroimmunology of rabies: New insights into an ancient disease

2023/10

Guido Moll
Guido Moll

H-Index: 21

Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS …

Frontiers in Immunology

2023/9/19

COVID-19 Lessons Learned for Biobanks

2023/9/1

Pedro Silva Couto
Pedro Silva Couto

H-Index: 4

Guido Moll
Guido Moll

H-Index: 21

Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach

npj Aging

2023/8/24

Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization

Frontiers in Immunology

2023/8/10

Ang II Promotes ET-1 Production by Regulating NOX2 Activity Through Transcription Factor Oct-1

Arteriosclerosis, Thrombosis, and Vascular Biology

2023/8

Effects of Atrazine exposure on human bone marrow-derived mesenchymal stromal cells assessed by combinatorial assay matrix

Frontiers in Immunology

2023/7/31

Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical …

2023/6/21

Raghavan Chinnadurai
Raghavan Chinnadurai

H-Index: 14

Guido Moll
Guido Moll

H-Index: 21

Mesenchymal Stem/Stromal Cells: SYSTEMATIC REVIEW AND META-ANALYSIS OF CELL THERAPY FOR COVID-19: GLOBAL CLINICAL TRIAL LANDSCAPE, PUBLISHED SAFETY/EFFICACY OUTCOMES, CELL …

2023/5

Next generation MSC therapy manufacturing, potency and mechanism of action analysis

Frontiers in Immunology

2023/4/21

Raghavan Chinnadurai
Raghavan Chinnadurai

H-Index: 14

Guido Moll
Guido Moll

H-Index: 21

Mesenchymal stem/stromal cells as a therapeutic tool in cell-based therapy and regenerative medicine: an introduction expertise to the topical collection

2022/10/8

Guido Moll
Guido Moll

H-Index: 21

Advances in Heart Transplantation

Frontiers in Immunology

2022/6/27

Guido Moll
Guido Moll

H-Index: 21

See List of Professors in Guido Moll University(Charité - Universitätsmedizin Berlin)

Co-Authors

academic-engine